切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - DREADD Ligands - 5-HT3 Receptors - Myosin II ATPases - Monocarboxylate transporters (MCTs)

10 件产品

每页
清除全部
  1. Ondansetron
    B2241 Ondansetron
    中文名: 昂丹司琼
    Target: 5-HT3 Receptors
    Summary: 血清素5-HT3受体拮抗剂
      ≥7.33 mg/mL
      insoluble in H2O
  2. VUF 10166
    B2259 VUF 10166
    Target: 5-HT3 Receptors
    Summary: 5-HT3受体拮抗剂
      ≥38.8 mg/mL
      insoluble in H2O
  3. (-)-Blebbistatin
    B1387 (-)-Blebbistatin
     3 Citation
    中文名: 布雷他汀
    Target: Myosin II ATPases
    Summary: 非肌肉肌球蛋白II型ATP酶抑制剂
      ≥14.62 mg/mL
      insoluble in H2O
  4. Tropisetron Hydrochloride
    B2258 Tropisetron Hydrochloride
    中文名: 盐酸托烷司琼
    Target: 5-HT3 Receptors
    Summary: 5-HT3受体拮抗剂
      ≥28.4 mg/mL
      ≥9.7 mg/mL
  5. Ondansetron HCl
    A5166 Ondansetron HCl
    中文名: 盐酸昂丹司琼
    Target: 5-HT3 Receptors
    Summary: 5-HT3受体拮抗剂
      ≥33.04 mg/mL
      insoluble in H2O
  6. Mosapride Citrate
    A1334 Mosapride Citrate
    中文名: 莫沙必利柠檬酸盐
    Target: 5-HT3 Receptors|5-HT4 Receptors
    Summary: 5-HT受体激动剂
      ≥30.7 mg/mL
      insoluble in H2O
  7. Vortioxetine
    A3926 Vortioxetine
    中文名: 沃替西汀
    Target: 5-HT1 Receptors|5-HT7 Receptors|5-HT3 Receptors|SERT
    Summary: 5-HT受体拮抗剂
      ≥14.92 mg/mL
      insoluble in H2O
  8. UK-5099
    A3899 UK-5099
     1 Citation
    Target: Monocarboxylate transporters (MCTs)|mitochondrial pyruvate carrier (MPC)
    Summary: MCTs和MPC抑制剂
      ≥28.8 mg/mL
      insoluble in H2O
  9. Clozapine N-oxide(CNO)
    A3317 Clozapine N-oxide(CNO)
     1 Citation
    中文名: 氯氮平的N-氧化物
    Target: DREADD Ligands
    Summary: Clozapine代谢产物,用于化学遗传学
      ≥17.15 mg/mL
      ≥49 mg/mL
  10. AR-C155858
    A3185 AR-C155858
    Target: Monocarboxylate transporters (MCTs)
    Summary: MCT1和MCT2抑制剂
      ≥52.5 mg/mL
      insoluble in H2O

10 件产品

每页